196 related articles for article (PubMed ID: 33565126)
1. Comorbidities in multiple myeloma and implications on survival: A population-based study.
Sverrisdóttir IS; Rögnvaldsson S; Thorsteinsdottir S; Gíslason GK; Aspelund T; Turesson I; Björkholm M; Gregersen H; Hveding Blimark C; Landgren O; Kristinsson SY
Eur J Haematol; 2021 Jun; 106(6):774-782. PubMed ID: 33565126
[TBL] [Abstract][Full Text] [Related]
2. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
[TBL] [Abstract][Full Text] [Related]
3. The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.
Mohammadi M; Cao Y; Glimelius I; Bottai M; Eloranta S; Smedby KE
BMC Cancer; 2015 Nov; 15():850. PubMed ID: 26537111
[TBL] [Abstract][Full Text] [Related]
4. The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study.
Gregersen H; Vangsted AJ; Abildgaard N; Andersen NF; Pedersen RS; Frølund UC; Helleberg C; Broch B; Pedersen PT; Gimsing P; Klausen TW
Cancer Med; 2017 Jul; 6(7):1807-1816. PubMed ID: 28639741
[TBL] [Abstract][Full Text] [Related]
5. Influence of specific comorbidities on survival after early-stage breast cancer.
Ewertz M; Land LH; Dalton SO; Cronin-Fenton D; Jensen MB
Acta Oncol; 2018 Jan; 57(1):129-134. PubMed ID: 29202645
[TBL] [Abstract][Full Text] [Related]
6. Statin use is associated with improved survival in multiple myeloma: A Swedish population-based study of 4315 patients.
Brånvall E; Ekberg S; Eloranta S; Wästerlid T; Birmann BM; Smedby KE
Am J Hematol; 2020 Jun; 95(6):652-661. PubMed ID: 32141627
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Freiburg and Charlson comorbidity indices in predicting overall survival in elderly patients with newly diagnosed multiple myeloma.
Kim SM; Kim MJ; Jung HA; Kim K; Kim SJ; Jang JH; Kim WS; Jung CW
Biomed Res Int; 2014; 2014():437852. PubMed ID: 25114902
[TBL] [Abstract][Full Text] [Related]
8. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
[TBL] [Abstract][Full Text] [Related]
9. Survival trends in elderly myeloma patients.
Jones A; Bowcock S; Rachet B
Eur J Haematol; 2021 Jan; 106(1):126-131. PubMed ID: 33037667
[TBL] [Abstract][Full Text] [Related]
10. Early mortality in multiple myeloma: the time-dependent impact of comorbidity: A population-based study in 621 real-life patients.
Ríos-Tamayo R; Sáinz J; Martínez-López J; Puerta JM; Chang DY; Rodríguez T; Garrido P; de Veas JL; Romero A; Moratalla L; López-Fernández E; González PA; Sánchez MJ; Jiménez-Moleón JJ; Jurado M; Lahuerta JJ
Am J Hematol; 2016 Jul; 91(7):700-4. PubMed ID: 27074204
[TBL] [Abstract][Full Text] [Related]
11. Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients.
Blimark C; Holmberg E; Mellqvist UH; Landgren O; Björkholm M; Hultcrantz M; Kjellander C; Turesson I; Kristinsson SY
Haematologica; 2015 Jan; 100(1):107-13. PubMed ID: 25344526
[TBL] [Abstract][Full Text] [Related]
12. Thrombosis is associated with inferior survival in multiple myeloma.
Kristinsson SY; Pfeiffer RM; Björkholm M; Schulman S; Landgren O
Haematologica; 2012 Oct; 97(10):1603-7. PubMed ID: 22511493
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort study.
Chari A; Mezzi K; Zhu S; Werther W; Felici D; Lyon AR
BMC Cancer; 2016 Nov; 16(1):912. PubMed ID: 27876016
[TBL] [Abstract][Full Text] [Related]
14. Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005-2016.
Toppila I; Kysenius K; Miettinen T; Lassenius MI; Lievonen J; Anttila P
Ann Hematol; 2022 Nov; 101(11):2485-2495. PubMed ID: 36098791
[TBL] [Abstract][Full Text] [Related]
15. Socioeconomic differences in patient survival are increasing for acute myeloid leukemia and multiple myeloma in sweden.
Kristinsson SY; Derolf AR; Edgren G; Dickman PW; Björkholm M
J Clin Oncol; 2009 Apr; 27(12):2073-80. PubMed ID: 19289627
[TBL] [Abstract][Full Text] [Related]
16. Comorbidity in Patients With Small-Cell Lung Cancer: Trends and Prognostic Impact.
Aarts MJ; Aerts JG; van den Borne BE; Biesma B; Lemmens VE; Kloover JS
Clin Lung Cancer; 2015 Jul; 16(4):282-91. PubMed ID: 25572007
[TBL] [Abstract][Full Text] [Related]
17. Variation in incidence and survival by ethnicity for patients with myeloma in England (2002-2008).
Samy EF; Ross J; Bolton E; Morris EJ; Oliver SE
Leuk Lymphoma; 2015; 56(9):2660-7. PubMed ID: 25651425
[TBL] [Abstract][Full Text] [Related]
18. Heart failure and levels of other comorbidities in patients with chronic obstructive pulmonary disease in a Swedish population: a register-based study.
Kaszuba E; Odeberg H; Råstam L; Halling A
BMC Res Notes; 2016 Apr; 9():215. PubMed ID: 27067412
[TBL] [Abstract][Full Text] [Related]
19. Fractures and survival in multiple myeloma: results from a population-based study.
Thorsteinsdottir S; Gislason G; Aspelund T; Sverrisdottir I; Landgren O; Turesson I; Björkholm M; Kristinsson SY
Haematologica; 2020 Apr; 105(4):1067-1073. PubMed ID: 31792034
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous comorbidities in patients with multiple myeloma: A 10-year retrospective cohort study from a Korean population.
Woo YR; Jung YJ; Kim JS; Kim M; Park YM; Min CK; Kim DW; Park HJ
Medicine (Baltimore); 2018 Oct; 97(43):e12825. PubMed ID: 30412074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
